CMS Removes NCD 220.6.20 From Publication 100-03

January 3, 2024

Effective October 13, 2023, CMS removed NCD 220.6.20 from Publication 100-03, the NCD Manual, ending coverage with evidence development (CED) for positron emission tomography (PET) beta amyloid imaging and permitting Medicare coverage determinations for PET beta amyloid imaging to be made by the Medicare Administrative Contractors under section 1862(a)(1)(A) of the Social Security Act.

This change will impact hospitals, physicians, suppliers, and other providers billing Medicare Administrative Contractors (MACs) for services provided to Medicare patients.

CLICK HERE for related documents, including a sample claims form and other information.